P. Ewing

发表

Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors

Z. Deng, Hong-Yu Ou, Wangxue Chen, 2015, Scientific Reports.

Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA

Wayne A Warner, Wangxue Chen, H. H. Xu, 2016, BMC Infectious Diseases.

Dynamics of Clarithromycin and Azithromycin Efficacies against Experimental Haemophilus influenzaePulmonary Infection

M. Mitten, J. Alder, A. Tovcimak, 1998, Antimicrobial Agents and Chemotherapy.

Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.

Q. Ye, H. H. Xu, P. Ewing, 2019, International journal of antimicrobial agents.

Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections

M. Mitten, R. Flamm, J. Alder, 2001, Antimicrobial Agents and Chemotherapy.

Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.

S. Ng, S. Rosenberg, H. Sham, 1999, Journal of medicinal chemistry.

Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens.

M. Mitten, R. Clark, S. Wang, 2000, Journal of medicinal chemistry.

Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.

Suoming Zhang, S. Zhang, M. Mitten, 2001, Journal of medicinal chemistry.

Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.

R. Henry, J. Plattner, R. Flamm, 1998, Journal of Medicinal Chemistry.

Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.

J. Plattner, R. Flamm, P. Ewing, 1998, Journal of Medicinal Chemistry.

Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacy.

S. Ng, P. Kovar, S. Rosenberg, 1999, Journal of medicinal chemistry.

Identification and characterization of A-105972, an antineoplastic agent.

D. Burns, S. Tahir, L. Alder, 2001, Cancer research.